Ringpu Bio-Technology to transfer stake in Zhong'an Bio

Tianjin Ringpu Bio-Technology (SZSE:300119) announced its intention to transfer a 48.4213% equity stake in its holding subsidiary, Hunan Zhong'an Biological Pharmaceutical Co. Ltd. ("Zhong'an Bio"), to Jiangxi Shuang胞胎 Biotechnology Co. Ltd. The deal, valued at CNY 11,475.8426 million, involves the transfer of the "Zhong'an Bio Expansion Project," a fundraising initiative. Post-transaction, Ringpu will retain a 20% stake in Zhong'an Bio, which will no longer be consolidated in Ringpu's financial statements. The decision, approved by the board on June 13, 2025, aligns with Ringpu's long-term strategy to deepen collaboration with customers and optimize its asset structure. The sale remains subject to shareholder approval.